ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

TEVETEN
Hypertension
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

TEVETEN Rx

Generic Name and Formulations:
Eprosartan (as mesylate) 400mg, 600mg; tabs.

Company:
Abbott Laboratories

Therapeutic Use:

Indications for TEVETEN:

Hypertension.

Adult:

Monotherapy: not volume depleted: initially 600mg once daily. Usual range: 400–800mg/day given as a single dose or in two divided doses.

Children:

Not established.

Pharmacological Class:

Angiotensin II receptor blocker.

Contraindications:

Concomitant aliskiren in patients with diabetes.

Warnings/Precautions:

Fetal toxicity may develop; discontinue if pregnancy is detected. Correct salt/volume depletion before beginning therapy or monitor closely. Renal impairment: monitor for worsening renal function. Renal artery stenosis. Severe CHF. Neonates. Pregnancy (Cat.D); monitor. Nursing mothers: not recommended.

Interactions:

See Contraindications. Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; monitor closely. Concomitant aliskiren in renal impairment (CrCl <60mL/min): not recommended. May be antagonized by, and renal toxicity potentiated by NSAIDs (including COX-2 inhibitors): monitor renal function in elderly and/or volume-depleted. Hyperkalemia with K+ supplements, K+ sparing diuretics, K+ containing salt substitutes.

Adverse Reactions:

Viral infection, injury, fatigue, abdominal pain, hypertriglyceridemia, arthralgia, depression, urinary tract or upper respiratory tract infection, rhinitis, pharyngitis, coughing, hypotension, rhabdomyolysis (rare).

Metabolism:

Hepatic. 98% protein bound.

Elimination:

Biliary, renal.

How Supplied:

Tabs—100

TEVETEN

  • 400mg tablets (Qty:30)
  • appx. price $111.00
GoodRx

Sign Up for Free e-newsletters